SEC Form 4 · accession 0001144204-15-072425
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry Wolfenson
Officer — See Remarks
Period of report
Dec 20, 2015
Accepted (ET)
Dec 23, 2015 · 6:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 20, 2015 | F | 2,743 | $4.48 | D | 80,534 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld in connection with the vesting of 8,750 restricted stock units, previously granted pursuant to the issuer's equity incentive plan as reported on December 21, 2012.
Remarks
Group President, Advanced Wound Care & Pharmaceutical Development